---
title: "Charles River Laboratories (CRL) stock analysis"
url: https://portfolio-terminal.com/analyse/crl
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: CRL
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Charles River Laboratories (CRL) stock analysis

> **Source:** Portfolio Terminal, "Charles River Laboratories (CRL) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/crl
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Charles River Laboratories (CRL) trades at $295.96, up 101.3% over the past year.
- Its 52-week range runs from $146.20 to $303.31; the price is 2.4% below that high.
- It sits 41.9% above its 200-day average of $208.54, the usual sign of a long-term uptrend.
- Its 30-day volatility is 35.3% annualized, which we rate high risk.

## About Charles River Laboratories

Charles River Laboratories (CRL) is a healthcare company operating in diagnostics & research. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

## What the chart is saying

In an uptrend, 2.4% under its 1-year high with no resistance above.

- Price is 8.8% above its 50-day average and 41.9% above its 200-day.
- The 50-day crossed above the 200-day on 2026-07-06 (a “golden cross”).
- RSI at 62 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $237.24 (-19.8%).

### Support and resistance

- Support near $237.24, 19.8% below the last close (the price turned there 2 times in the last year).
- Support near $228.64, 22.7% below the last close (the price turned there 2 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/crl